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The brainstem auditory evoked potential (BAEP) is 
being extensively used as a method for the evaluation of 
cochlear function in individuals with diagnosis of auditory 
neuropathy/auditory dyssynchrony (AN/AD). In the absence 
of otoacoustic emissions, many cases of AN/AD have been 
diagnosed by the presence of CM identified in the BAEP. Aim: 
to demonstrate the clinical applicability of extratympanic 
electrocochleography (ET-Ecochg) in the differential diagnosis 
of AN/AD compared to the BAEP. Method: a 4-year-old child 
with a diagnosis of AN/AD seen at the Audiological Research 
Center was submitted to ET-Ecochg with a 2000 Hz tone 
burst in rarefaction and condensation polarities. Results: 
the ET-Ecochg exam was illustrated. Using an appropriate 
protocol, it was possible to demonstrate CM and to confirm 
it in the Ecochg, with a recording quality superior to that 
obtained in the BAEP. Conclusion: ET-Ecochg permitted a 
more detailed analysis of CM compared to the BAEP, thus 
showing clinical applicability for the investigation of cochlear 
function in AN/AD.






BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY 74 (1) JANUARY/FEBRUARY 2008
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
INTRODUCTION
In the past 20 years, scientists have described pa-
tients with similar clinical findings, but with a wide variety 
of terms to name those symptoms, such as brainstem 
processing syndrome, central auditory dysfunction, neural 
synchrony disorder, auditory neuropathy, and recently 
auditory dyssynchrony.1,2 
The term auditory neuropathy was first used in a 
paper published in 19963 that attempted to classify patients 
that had a variety of auditory symptoms, a normal-functio-
ning cochlea, and altered cochlear nerve function.
In 2001, some authors1 suggested the term audi-
tory dyssynchrony instead of auditory neuropathy, as the 
cochlear nerve was not always injured, and therefore the 
old term would be semantically incorrect. Even with this 
recommendation, however, both terms are still used in 
papers that describe these patients. As a result, auditory 
neuropathy/dyssynchrony (AN/AD) has emerged as a 
third term.3-10 
AN/AD patients are subjects that may have normal 
tone thresholds or profound hearing loss. The condition is 
usually bilateral, but there are reports of unilateral cases in 
the literature. The disorder may be diagnosed at any age. 
Otoacoustic emissions (OAEs) and/or cochlear micropho-
nics (CMs) are present regardless of the degree of hearing 
loss. Auditory brainstem evoked potentials (ABEPs), mi-
ddle ear muscle reflexes and olivocochlear reflexes are 
absent. Audiograms, when they can be applied, may be 
flat or show an upward or downward-sloping curve or be 
completely irregular; findings usually do not match speech 
understanding difficulties.1,11-15 
It may be difficult to locate the injury site in AN/
AD, although the presence of OAEs and/or CMs suggests 
that outer hair cells (OHC) are intact. The ABEP wave 
I, however, which is generated by the myelin-sheathed 
peripheral portion of the cochlear nerve, is absent in this 
auditory condition. Symptoms suggest a disorder involving 
inner hair cells (IHC), the synapses between IHC and the 
auditory nerve, and peripheral portions of the cochlear 
nerve.16-18 
Although the risk factors for AN/AD are unclear, 
some of the children with this disorder have a history of 
neonatal events such as premature birth, low birth weight, 
anoxia and hyperbilirubinemia.19 
The presence of OAEs associated with absent ABEPs 
is pathognomonic of AN/AD, although in some cases 
OAE recordings may be absent. Consequently, depending 
on when the initial diagnosis is made, OAEs and absent 
ABEPs will not provide a final definition and diagnosis of 
AN/AD. In such cases, the presence of CMs becomes the 
determinant finding in the differential diagnosis of this 
condition.1,20,21 Some authors have proposed that AN/AD 
be defined as a condition with absent or abnormal ABEPs 
including wave I, associated with present OAEs and/or 
CMs.20 
In the past 10 years, many papers on auditory neu-
ropathy have underlined the role of CMs, which are now 
analyzed with greater care in AN/AD patients. Reports 
in the literature have shown that CMs in these patients 
are more prominent, having an abnormally increased 
amplitude,23-26 and persist for up to 4 to 6 milliseconds 
after click stimulation,22 contrary to what is found in nor-
mal subjects.
Electrocochleography (ECoG), which had a sig-
nificant clinical impact in the diagnosis and monitoring 
of Ménière’s disease,27-29 and which objectively assesses 
cochlear potentials, is the indicated clinical procedure 
to analyze CMs.30,31 The recent development of various 
non-invasive electrodes have reawakened interest in the 
clinical use of ECoG.27,32 Although transtympanic electro-
cochleography (TT-ECoG) yields recordings with higher 
amplitudes and lower test-retest variability, it has the di-
sadvantage of being an invasive procedure. Extratympanic 
electrocochleography (ET-ECoG), therefore, is clinically 
more useful in this context, supporting an audiological 
diagnosis and increasing knowledge about cochlear func-
tion in AN/AD.
Even though ECoG is the most appropriate proce-
dure for assessing cochlear function, and therefore helping 
identify CMs and diagnosing AN/AD, there is little infor-
mation in the literature on its use in this disorder.4,5,33 
ABEP testing has also been widely used in identi-
fying CMs, the rationale being that insertion phones avoid 
the extensive magnetic field caused by supra-aural phones, 
which obscure cochlear potentials and, at times, the nerve 
action potential. Furthermore, CMs may be identified by 
recording auditory evoked potentials using negative and 
positive polarity acoustic stimuli in which results may be 
compared, given that CMs are affected by the stimulus 
polarity, contrary to ABEPs.1,20,25,34 
To confirm the presence of CMs, some researchers 
block the insertion phone plastic tube to guarantee that 
recordings are auditory neurophysiological responses that 
truly reflect acoustic stimulation, rather than electrical 
artifacts.3,20,24 
Although the literature has suggested that cochlear 
function is normal in AN/AD,3,13,34 it is important to analyze 
CMs in these cases; a number of findings about this specific 
cochlear potential in AN/AD patients appear to show that 
the cochlea may be dysfunctional.23-26 
The use of ABEP testing of CMs seems inadequate, 
as CMs cannot be carefully analyzed by this method. A 
better analysis of CM amplitude and morphology would 
be obtained with tone bursts, rather than the clicks usually 
used in ABEP testing.28,35,36 
Based on this assumption, the aim of this paper 
was to demonstrate the clinical applicability of ET-ECoG 
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in the differential diagnosis of AN/AD, compared to ABEP 
testing.
MATERIAL AND METHOD
A case description is made of a four-year-old child 
diagnosed with AN/AD. Following a term birth and the 
presentation of apnea and cyanosis three days later, the 
child was admitted into hospital and given gentamycin 
for 14 days. Hyperbilirubinemia ensued, requiring blood 
transfusion. Free-field audiological testing found a decrea-
sed auditory threshold that suggested a downward-sloping 
configuration moderate to severe hearing loss. Responses 
to intense speech were inconsistent. Immitance testing sho-
wed normal tympanometric curves and absent contralateral 
and ipsilateral acoustic reflexes. Transient and distortion 
product OAEs were present in both ears.
ABEP testing and ET-ECoG were done to aid in the 
differential diagnosis of AN/AD. The test protocol is des-
cribed in Table 1. Both ABEP testing and ET-ECoG were 
done in an acoustically and electromagnetically treated 
room, using a Bio-logic Systems Corp.® Navigator Pro 
device, version 4.2.0. The skin was cleaned with abrasive 
paste; a small amount of electrolytic paste was placed on 
disposable electrodes. After electrode placement, the ca-
bles were connected. An Ear Tone 3A earphone was used. 
The following electrode arrangement was used for ABEP 
testing: active-frontal; reference-mastoid, and ground on 
the contralateral mastoid to the stimulated side. The active 
and ground ET-ECoG electrodes were placed frontally, and 
the reference electrode (TIPtrode model) was introduced 
into the acoustic canal.
Etymotic Research laboratories, based on insertion 
phone structure, developed the TIPtrode. It contains a 
plastic tube that conveys sound and that connects to the 
insertion phone tube. It is coated by a thin gold layer that 
conducts the auditory evoked potential electrical activity to 
the preamplifier.37 The TIPtrode not only initiates acous-
tic stimuli, but is also the receptor for electrical activity. 
Following the registration protocol, the procedure for 
both ABEP testing and ET-ECoG was repeated in rarefac-
tion polarity by blocking the insertion phone plastic tube 
with appropriate forceps that had two rubber olives on its 
extremity to avoid damage to the plastic tube and to stop 
the acoustic stimulus from reaching the auditory canal. In 
these circumstances, the cochlear potential disappears, 
and only any signal electrical artifacts remain.20,24,38 This 
sequence aimed to assure the reliability of recordings and 
to confirm the biological response.
RESULTS
Figure 1 shows ABEP recordings in both ears in a 
four-year-old child diagnosed with AN/AD. CMs may be 
seen in the two upper recordings (R-rarefaction, and C-
condensation) as well as absence of neural components. 
Cochlear CMs were not completely cancelled in the 
intermediate recording (A-alternated). The lower recor-
ding (Bloq-blocked) shows the absence of a biological 
response.
Table 1. Protocol for ABEP testing and ET-ECoG recording.
Parameters ABEP ET-ECoG
Type of stimulus    click
Tone burst - 
2,000Hz
Stimulus velocity    21.1 19.30
Stimulus intensity    90dBnHL 80dBnHL
Stimulus polarity    
Rarefaction/con-
densation    
Rarefaction/con-
densation
Stimulus duration    100µs 1-3-1 (linear)
Promediated stimulus    2000 replicated    500 replicated
Masking No No
Type of earphone    Insertion Insertion
Analysis time    15ms 10.66ms
High-pass filter    100Hz 30Hz
Low-pass filter    3000Hz 5000Hz
Amplification (gain)    - 75.000
Artifact rejection limit    
Up to 10% of the 
total    
Up to 10% of the 
total    
Pre-stimulus interval    - 1ms
Figure 1 - Extratympanic electrocochleography in auditory neuropa-
thy/dyssynchrony - ABEP recordings in AN/AD 
Figure 2 shows ET-ECoG recordings in both ears 
in a four-year-old child diagnosed with AN/AD. CMs may 
be seen in the two upper recordings (R-rarefaction, and 
C-condensation) as well as absence of neural components. 
Cochlear CMs were not completely cancelled in the in-
termediate recording (A-alternated). The lower recording 
(Bloq-blocked) shows the absence of a biological respon-
se. CMs are seen with better quality in these recordings, 
making it possible to analyze CM morphology, amplitude 
and duration more precisely.
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Figure 3 shows inversion of CM tracings at 180° on 
the upper ET-ECoG recording when using rarefaction (R) 
e condensation (C) polarities. CM authenticity is shown 
on the lower recording, where the cochlear potential di-
sappears when blocking the insertion phone tube (Bloq-
blocked).
in which blocking the plastic tube to confirm a biological 
response is not possible.
ET-ECoG is a non-invasive technique that may be 
used in young children, without sedation; the diagnosis 
of AN/AD, therefore, may be expedited. The recording 
amplitude is increased, compared to ABEP testing, by 
locating the electrodes closer to the site of origin of co-
chlear potentials, which is extremely relevant in AN/AD, 
as published papers have shown that CMs are ampler in 
such testing conditions.22-26 Higher quality recordings make 
it possible to evaluate not only the amplitude but also the 
duration of CMs; the literature suggests that CMs are more 
prolonged in AN/AD, compared to normal subjects.
A further points is that ET-ECoG also evaluates 
cochlear function, thereby providing an audiological as-
sessment if OAEs are absent.
It is important to note that even when using ET-
ECoG to evaluate CMs in AN/AD patients, an appropriate 
protocol using strategies to assure recording reliability 
should be applied. Tone burst stimulation should be used, 
and rarefaction and condensation polarities should be 
used to confirm inversion of recordings, and therefore, 
confirmation of CMs. We also recommend using insertion 
phones to provide confirmation of a biological response, 
where the plastic tube may be blocked to discard possible 
signal electrical artifacts.
CONCLUSION
Our findings show that ET-ECoG may be applied 
clinically in the differential diagnosis of AN/AD, making it 
possible to analyze cochlear function in greater detail com-
pared to ABEP testing, particularly in identifying CMs.
We aimed to provide additional data in support of 
a more effective diagnosis of AN/AD, especially in small 
children in whom electrophysiological methods frequen-
tly are the only available tools for evaluating auditory 
function.
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